Jianwen Feng

Jianwen Feng is the Head of Antibody Research and CMC at Hillstar Bio. Prior to this, Jianwen held roles such as Sr Director of Antibody Discovery and Protein Science at Pyxis Oncology, Director of QC-IND at MassBiologics, Sr Principal Scientist/Associate Director at Jounce Therapeutics Inc., and Senior Scientist at Shire HGT. Jianwen's career also includes work as a Scientist at Lonza and Percivia. With a Ph.D. in Biochemistry from Boston College, Jianwen has a strong background in protein analytics and antibody research, with a focus on developing novel therapies and improving quality control processes.